273 related articles for article (PubMed ID: 8512326)
1. Factors affecting the species-homologous and species-heterologous binding of mitochondrial ATPase inhibitor, IF1, to the mitochondrial ATPase of slow and fast heart-rate hearts.
Rouslin W; Broge CW
Arch Biochem Biophys; 1993 Jun; 303(2):443-50. PubMed ID: 8512326
[TBL] [Abstract][Full Text] [Related]
2. Novel difference in IF1 reactivity to Zn2+ in rabbit versus rat cardiomyocytes, mitochondria, and submitochondrial particles.
Rouslin W; Broge CW
Biochem Biophys Res Commun; 1996 Oct; 227(1):8-14. PubMed ID: 8858095
[TBL] [Abstract][Full Text] [Related]
3. Content and binding characteristics of the mitochondrial ATPase inhibitor, IF1, in the tissues of several slow and fast heart-rate homeothermic species and in two poikilotherms.
Rouslin W; Frank GD; Broge CW
J Bioenerg Biomembr; 1995 Feb; 27(1):117-25. PubMed ID: 7629043
[TBL] [Abstract][Full Text] [Related]
4. Analysis of factors affecting functional assays for estimating IF1, the mitochondrial ATPase inhibitor.
Rouslin W; Broge CW
Anal Biochem; 1994 Oct; 222(1):68-75. PubMed ID: 7856873
[TBL] [Abstract][Full Text] [Related]
5. IF1 function in situ in uncoupler-challenged ischemic rabbit, rat, and pigeon hearts.
Rouslin W; Broge CW
J Biol Chem; 1996 Sep; 271(39):23638-41. PubMed ID: 8798581
[TBL] [Abstract][Full Text] [Related]
6. Regulation of the mitochondrial adenosine 5'-triphosphatase in situ during ischemia and in vitro in intact and sonicated mitochondria from slow and fast heart-rate hearts.
Rouslin W; Broge CW
Arch Biochem Biophys; 1990 Jul; 280(1):103-11. PubMed ID: 2141243
[TBL] [Abstract][Full Text] [Related]
7. ATPase activity, IF1 content, and proton conductivity of ESMP from control and ischemic slow and fast heart-rate hearts.
Rouslin W; Broge CW; Guerrieri F; Capozza G
J Bioenerg Biomembr; 1995 Aug; 27(4):459-66. PubMed ID: 8595981
[TBL] [Abstract][Full Text] [Related]
8. [Interaction of ATPase from submitochondrial fragments and a natural inhibitor protein during delta-mu-H+ generation on a membrane].
Vasil'eva EA; Panchenko MV; Vinogradov AD
Biokhimiia; 1989 Sep; 54(9):1490-8. PubMed ID: 2531616
[TBL] [Abstract][Full Text] [Related]
9. Investigation of the role and mechanism of IF1 and STF1 proteins, twin inhibitory peptides which interact with the yeast mitochondrial ATP synthase.
Venard R; Brèthes D; Giraud MF; Vaillier J; Velours J; Haraux F
Biochemistry; 2003 Jun; 42(24):7626-36. PubMed ID: 12809520
[TBL] [Abstract][Full Text] [Related]
10. The mitochondrial adenosine 5'-triphosphatase in slow and fast heart rate hearts.
Rouslin W
Am J Physiol; 1987 Mar; 252(3 Pt 2):H622-7. PubMed ID: 2950775
[TBL] [Abstract][Full Text] [Related]
11. The inhibitor protein (IF1) promotes dimerization of the mitochondrial F1F0-ATP synthase.
García JJ; Morales-Ríos E; Cortés-Hernandez P; Rodríguez-Zavala JS
Biochemistry; 2006 Oct; 45(42):12695-703. PubMed ID: 17042487
[TBL] [Abstract][Full Text] [Related]
12. Activation of a complex of ATPase with the natural protein inhibitor in submitochondrial particles.
Khodjaev EYu ; Komarnitsky FB; Capozza G; Dukhovich VF; Chernyak BV; Papa S
FEBS Lett; 1990 Oct; 272(1-2):145-8. PubMed ID: 2146159
[TBL] [Abstract][Full Text] [Related]
13. Factors affecting the reactivation of the oligomycin-sensitive adenosine 5'-triphosphatase and the release of ATPase inhibitor protein during the re-energization of intact mitochondria from ischemic cardiac muscle.
Rouslin W
J Biol Chem; 1987 Mar; 262(8):3472-6. PubMed ID: 2950098
[TBL] [Abstract][Full Text] [Related]
14. Mitochondrial adenosinetriphosphatase inhibitor protein: reversible interaction with complex V (ATP synthetase complex).
Galante YM; Wong SY; Hatefi Y
Biochemistry; 1981 Apr; 20(9):2671-8. PubMed ID: 6263316
[TBL] [Abstract][Full Text] [Related]
15. Effect of reversible ischemia on the activity of the mitochondrial ATPase: relationship to ischemic preconditioning.
Vander Heide RS; Hill ML; Reimer KA; Jennings RB
J Mol Cell Cardiol; 1996 Jan; 28(1):103-12. PubMed ID: 8745218
[TBL] [Abstract][Full Text] [Related]
16. Pressure effects on the interaction between natural inhibitor protein and mitochondrial F1-ATPase.
Fornells LA; Guimarães-Motta H; Nehme JS; Martins OB; Silva JL
Arch Biochem Biophys; 1998 Jan; 349(2):304-12. PubMed ID: 9448719
[TBL] [Abstract][Full Text] [Related]
17. Effects of Zn2+ on the activity and binding of the mitochondrial ATPase inhibitor protein, IF1.
Rouslin W; Broge CW; Chernyak BV
J Bioenerg Biomembr; 1993 Jun; 25(3):297-306. PubMed ID: 8349574
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of ATP conservation during ischemia in slow and fast heart rate hearts.
Rouslin W; Broge CW
Am J Physiol; 1993 Jan; 264(1 Pt 1):C209-16. PubMed ID: 8430769
[TBL] [Abstract][Full Text] [Related]
19. Functional transitions of F0F1-ATPase mediated by the inhibitory peptide IF1 in yeast coupled submitochondrial particles.
Galkin M; Venard R; Vaillier J; Velours J; Haraux F
Eur J Biochem; 2004 May; 271(10):1963-70. PubMed ID: 15128305
[TBL] [Abstract][Full Text] [Related]
20. Spontaneous aggregation of the mitochondrial natural ATPase inhibitor in salt solutions as demonstrated by gel filtration and neutron scattering. Application to the concomitant purification of the ATPase inhibitor and F1-ATPase.
Klein G; Satre M; Zaccai G; Vignais PV
Biochim Biophys Acta; 1982 Aug; 681(2):226-32. PubMed ID: 6214274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
